OneDigital Investment Advisors LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
OneDigital Investment Advisors LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$228,834
-38.0%
5,992
-7.6%
0.01%
-54.5%
Q4 2022$368,826
+44.1%
6,482
+0.2%
0.01%
+22.2%
Q3 2022$256,000
+0.8%
6,466
+12.2%
0.01%
-18.2%
Q2 2022$254,000
+10.9%
5,765
+0.3%
0.01%
+22.2%
Q1 2022$229,000
-0.9%
5,7500.0%0.01%
+12.5%
Q4 2021$231,000
+13.8%
5,750
+15.0%
0.01%0.0%
Q3 2021$203,000
-11.7%
5,000
-1.1%
0.01%
-11.1%
Q2 2021$230,000
-12.9%
5,055
-20.0%
0.01%
-25.0%
Q1 2021$264,000
+14.8%
6,321
+17.3%
0.01%0.0%
Q4 2020$230,0005,3870.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders